Log in with your email address username.


Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

[Comment] Rheumatology—a call for papers

Rheumatoid and autoimmune diseases are a heterogeneous group of disorders, many of which are of unknown aetiology and have heterogeneous clinical presentation. Often difficult to diagnose and to treat, these conditions are an under-appreciated group of non-communicable diseases that, according to latest Global Burden of Disease estimates,1 contribute as much as 20% of years lived with disability, worldwide. Research into the treatment, epidemiology, and public health and education interventions that might help to combat this diverse group of diseases is an urgent, unmet need.